## Induction Therapy for Lupus Nephritis **Key Point:** Cyclophosphamide is the gold-standard induction agent for severe lupus nephritis (Class III and IV). It is a nitrogen mustard alkylating agent that causes profound immunosuppression and has superior efficacy in inducing long-term remission compared to other agents. ### Mechanism of Cyclophosphamide Cyclophosphamide is a prodrug that requires hepatic activation to form active alkylating metabolites. These metabolites cross-link DNA, leading to: - Depletion of B and T lymphocytes - Suppression of autoantibody production - Reduction in immune complex deposition in the glomeruli ### NIH Induction Protocol for Lupus Nephritis ```mermaid flowchart TD A[Severe Lupus Nephritis<br/>Class III or IV]:::outcome --> B[High-dose Corticosteroids<br/>1 mg/kg/day]:::action B --> C[Cyclophosphamide Induction]:::action C --> D[IV pulse: 0.5-1 g/m²<br/>monthly × 6 months]:::action D --> E[Maintenance Therapy<br/>Azathioprine or MMF]:::action E --> F[Long-term Remission]:::outcome ``` **High-Yield:** The standard induction regimen is intravenous (IV) cyclophosphamide 0.5–1 g/m² monthly for 6 months, followed by maintenance therapy with azathioprine or mycophenolate mofetil (MMF). This approach achieves remission in 60–70% of patients with Class IV nephritis. ### Comparison of Agents for Lupus Nephritis | Agent | Mechanism | Role | Efficacy | Toxicity | |-------|-----------|------|----------|----------| | **Cyclophosphamide** | Alkylating agent | Induction | Superior (60–70% remission) | Hemorrhagic cystitis, infertility, infection | | Mycophenolate mofetil | IMPDH inhibitor | Induction/Maintenance | Good (comparable to CYC in some trials) | GI upset, diarrhea | | Methotrexate | Antimetabolite | Maintenance only | Moderate | Hepatotoxicity, cytopenias | | Azathioprine | Purine antagonist | Maintenance | Moderate | Hepatotoxicity, pancreatitis | **Clinical Pearl:** Although mycophenolate mofetil (MMF) has shown comparable efficacy to cyclophosphamide in some recent trials (ALMS, Aspreva), cyclophosphamide remains the standard of care for severe, rapidly progressive lupus nephritis because of its proven long-term renal outcomes and lower relapse rates. ### Toxicity Mitigation 1. **Hemorrhagic cystitis:** Prevented by aggressive hydration and mesna (2-mercaptoethane sulfonate) 2. **Infertility:** Counsel patients; consider gonadal cryopreservation in reproductive-age patients 3. **Infection:** Monitor for opportunistic infections; use prophylaxis as needed 4. **Malignancy:** Long-term risk; monitor surveillance ### Why Cyclophosphamide Over Other Options - **Methotrexate:** Maintenance agent only; not potent enough for induction of severe nephritis - **Leflunomide:** Teratogenic; not used in SLE; primarily for rheumatoid arthritis - **Sulfasalazine:** Mild-to-moderate SLE manifestations; insufficient for Class IV nephritis [cite:Harrison 21e Ch 298]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.